Shoppers Drug Mart partners with Avicanna
Avicanna announced Tuesday that Shoppers Drug Mart has selected Avicanna as its partner to transition its Medical Cannabis by Shoppers business.
Pharmacy
CVS Health to close acquisition of Signify Health
CVS Health announced it expects to complete its acquisition of Signify Health on or around March 29, 2023, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement.
NACDS applauds House introduction of bipartisan legislation helping to preserve Medicare pharmacy access
The National Association of Chain Drug Stores (NACDS) is applauding today the introduction of bipartisan legislation in the U.S. House of Representatives (H.R. 1770) that would help preserve Americans’ access to critical pharmacy-based services.
Camber launches generic Protonix
Camber Pharmaceuticals is pleased to announce the addition of pantoprazole sodium for injection to its current portfolio.
NACDS Foundation Research Project demonstrates community-based opportunities to improve statin adherence in diabetes care
On March 16, the second phase of the NACDS Foundation’s Gaps in Care research project — “Community pharmacist intervention to optimize statin adherence in diabetes care: The GuIDE-S study” — was published in the Journal of the American Pharmacists Association.
Comer, Bedoya speaking at NCPA 2023 Congressional Pharmacy Fly-In
ALEXANDRIA, Va. – The National Community Pharmacists Association announced that Rep. James Comer (R-Ky.), chairman of the House Committee on Oversight and Accountability, and Federal Trade Commissioner Alvaro Bedoya will be giving remarks at NCPA’s upcoming Congressional Pharmacy Fly-In.
NACDS praises continued focus and diligence on PBM reform
ARLINGTON, Va. – National Association of Chain Drug Stores (NACDS) president and chief executive officer Steven Anderson issued the following statement today upon passage of the Pharmacy Benefit Manager Transparency Act (S. 127) by the U.S.
Soleo Health CEO Drew Walk named to NHIA board of directors
Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the appointment of Chief Executive Officer Drew Walk to the National Home Infusion Association (NHIA) 2023-2024 Board of Directors.
CHPA issues statement on FDA postponing April 12 NDAC meeting
WASHINGTON – The Consumer Healthcare Products Association (CHPA) released the below statement following the U.S.
NACDS makes recommendations as Senate Committee explores health care workforce topics
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) this week put forth its priority public policy issues as ideal solutions for a U.S. Senate Committee’s interest in health care workforce shortages.
New integration streamlines MedOne prior authorization processes
MedOne Pharmacy Benefit Solutions announces a new collaboration with CoverMyMeds that will allow members enrolled in a MedOne benefit plan to experience a streamlined prior authorization process via direct integration with CoverMyMeds’ network of prescribers, EHR (electronic health records) systems,
Camber launches generic Thyro-Tabs
PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of levothyroxine sodium tablets, USP to its current portfolio.
HDA names new federal government affairs, communications appointments
The Healthcare Distribution Alliance (HDA) announces new appointments to its Government Affairs and Communications teams: Kirsten Wing Named Director of Federal Government Affairs Kirsten Wing joined the association in early March as Director of Federal Government Affairs. In this position, Ms.
What do consumers want from their pharmacy experience
After three years of the pandemic, consumers are returning to health care. But they are not returning to the same health care landscape, nor are they behaving in the same manner.
NACDS backs Rep. Carter’s Drug Pricing Transparency in Medicaid Act
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is lauding legislation by U.S. Rep. Buddy Carter (R-GA) that will crack down on tactics by which “pharmaceutical benefit manipulator” middlemen maximize profits at the expense of patients, pharmacies, and others.